You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石四藥集團(02005.HK)2024年淨利潤約10.61億港元 同比減少19.5%
格隆匯 03-28 12:20

格隆匯3月17日丨石四藥集團(02005.HK)發佈公告,2024年全年實現銷售收入以人民幣計約52.66億元,同比減少9.6%;以港元計,全年銷售收入約57.73億港元,同比減少10.7%,同期毛利率50.4%,同比下降5.6個百分點;實現淨利潤約10.61億港元,同比減少19.5%。董事議決派發末期息0.095港元╱股,全年共派息0.175港元╱股,同比增長2.9%。

知識產權保護工作成效顯著。2024年,集團申請專利88項,授權專利51項。目前,累計申請專利552項,授權340項。目前,集團擁有有效專利315件,其中發明專利155件。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account